Different conformations of EGF-induced receptor dimers involved in signaling and internalization
The structural basis of the activation of EGF receptors (EGFR) is still a matter of debate despite the importance of this target in cancer treatment. Whether agonists induce dimer formation or act on pre-formed dimers remain discussed. Here we provide direct evidence that EGFR activation results from EGF-induced dimer formation. This is well illustrated by i) a large increase in time resolved (TR)-FRET between snap-tagged EGFR subunits induced by agonists, ii) a similar effect of Erlotinib-related TK inhibitors despite the inactive state of the binding domain of the subunits, and iii) a similar TR-FRET efficacy in EGFR dimers stabilized by EGF or erlotinib with binding domains in active and inactive states, respectively. Surprisingly, TK inhibitors do not inhibit EGF-induced EGFR internalization despite their ability to fully block EGFR signaling. Only Erlotinib-related TK inhibitors promoting asymmetric dimers could slow down this process, while the lapatinib-related ones have almost no effect. These results reveal that the conformation of the intracellular TK dimer, rather than the known EGFR signaling is critical for EGFR internalization. These results also illustrate clear differences in the mode of action of TK inhibitors on the EGFR.